BLUE SEPTEMBER: Men Facing Up To Cancer
Blue September sees the Australian Cancer Research Foundation turning blue for a whole month to raise awareness for cancer in men. We're asking everyone to please Get Blue and support ...
Childhood cancer on notice
Official opening of the new ACRF Drug Discovery Centre "Tonight, together, we have put childhood cancer on notice. "Tonight, we have glimpsed a not to distant future where no child who has ...
BLUE SEPTEMBER: Men Facing Up To Cancer
Blue September sees the Australian Cancer Research Foundation turning blue for a whole month to raise awareness for cancer in men. We’re asking everyone to please Get Blue and support BLUE SEPTEMBER.
Supporting the Australian Cancer Research Foundation and Bowel Cancer Australia, Blue September is launches across the nation on 1st September, and it is about one thing: men facing up to cancer.
Why Blue? Its Simple – Blue is for boys!
Childhood cancer on notice
Official opening of the new ACRF Drug Discovery Centre
“Tonight, together, we have put childhood cancer on notice.
“Tonight, we have glimpsed a not to distant future where no child who has cancer need suffer,” declared Bob Muscat, chairman of the Children’s Cancer Institute Australia at the August 19 launch of the $3.1m ACRF Drug Discovery Centre.
Mr Muscat joined University of New South Wales chancellor David Gonski, Children’s Cancer Institute Australia executive director Michelle Haber, CCIA founder Jack Kassas, and Australian Cancer Research Foundation chairman Tom Dery to officially open the new ACRF-funded facilities at the CCIA, part of the Lowy Cancer Research Centre at UNSW.
The ACRF Drug Discovery Centre will develop new and improved treatments for childhood cancers.
It houses customised technology that enables one year’s medical research to be done in just a few days.
New era of personalised medicine
Chairman of the Australian Cancer Research Foundation Tom Dery said findings from the recently opened $3.1 ACRF Drug Discovery Centre would lead to a new era of personalised medicine.
“Personalised medicine is the future of cancer therapy,” Mr Dery said.
“The days of the one-size-fits-all approach to medicine will soon be over, thanks to the work of researchers at facilities such as the ACRF Drug Discovery Centre.
“Targeted drug treatments can ensure fewer long term side effects and better results, and that’s the kind of outcome that motivates the people who so kindly donate to the Australian Cancer Research Foundation,” he said.
Eureka! ACRF medical adviser wins top science prize
ACRF congratulates Philip Hogg
Philip Hogg, director of the Lowy Cancer Research Centre at UNSW, has won the 2010 Eureka Prize for Medical Research Translation.
The prestigious award, announced in Sydney on August 17, is for research leading to the development of a novel class of anti-cancer drugs. It also recognises Professor Hogg’s work in monitoring real-time cell death during chemotherapy.
“Professor Hogg has been a member of the ACRF Medical Research Advisory Committee since 2003,” said ACRF chairman, Tom Dery.
City2Surf: The $80,000 Dream
A very B-I-G congratulations and thank you to everyone who supported the Cancer Research City2Surf Dream Team!
The ACRF Dream Team – led by staffers Claire, Mahsa and Natasha – is jubilant following a massive effort at last Sunday’s City2Surf which will see an extra $80,000 go directly to cancer research.
The early morning start and chilly weather couldn’t keep them and close to 800 other Australian Cancer Research Foundation entrants from lining up for this annual race from the Sydney business district to Bondi beach.
One of the most inspiring participants in the 80,000 strong field was Fred Pham.
Mr Pham, schoolteacher and father of five young children, has only a short time to live. This did not stop him walking the 14 kilometre course with two of his sons and becoming the event’s most successful individual fundraiser.

Connect with Us